Abstract:Nuclear factor-kappa B (NF-κB), which is reported to play an important role in the pathogenesis of depression, also has a central role in the genesis and progression of inflammation. Here, we have targeted the nuclear translocation of NF-κB using 4-methyl-N1-(3-phenyl-propyl)-benzene-1,2-diamine (JSH-23) to elucidate its role in depression. We investigated the antidepressant-like effects of JSH-23 in the chronic mild stress (CMS) mouse model, which is a valid, reasonably reliable, and useful model of depression. The antidepressant-like effects of JSH-23 were evaluated using the sucrose preference test (SPT) and the forced swimming test (FST). We also assessed inflammatory markers [interleukin (IL)-6 and tumor necrosis factor-α (TNF-α)] and components of antioxidant defense [superoxide dismutase (SOD) and nuclear factor erythroid-2-related factor 2 (Nrf 2)] in the hippocampus. Fluoxetine, a classical antidepressant, was used in this study as a positive control. Administration of JSH-23 significantly prevented the decreased sucrose preference in the SPT and prevented the increased immobility time in the FST caused by CMS, but had no effect on locomotor activity. Expression of NF-κB p65 protein in the hippocampus was decreased, and elevated levels of IL-6 and TNF-α were reduced, after JSH-23 administration. In addition to its anti-inflammatory effect, JSH-23 treatment increased the expression of SOD and Nrf 2 in the hippocampus, suggesting that it strengthens antioxidant defense. The current study demonstrated that inhibiting the NF-κB signaling cascade using JSH-23 prevented depressive-like behaviors by decreasing inflammation and improving antioxidant defense in the hippocampus. We concluded that NF-κB activation plays an important role in the pathophysiology of depression and that targeting NF-κB signaling may provide a novel and effective therapy for depression. Additional preclinical studies and clinical trials are, however, needed to further elucidate the effects of this therapeutic strategy.

Glycogen synthase kinase-3β is critical for interferon-α-induced serotonin uptake in human Jurkat T cells

STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior

Role of Serotonin Receptor-1a in Interferon-Induced Depression

Interferon-alpha-induced Modulation of Glucocorticoid and Serotonin Receptors As a Mechanism of Depression.

5-HT1A Receptor and Apoptosis Contribute to Interferon-Α-induced “Depressive-Like” Behavior in Mice

Glycogen synthase kinase‐3ß supports serotonin transporter function and trafficking in a phosphorylation‐dependent manner

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Cytokines and serotonin transporter in patients with major depression

The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters

p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms

Ginsenoside Rk3 Regulates Tryptophan Metabolism along the Brain-Gut Axis by Targeting Tryptophan Hydroxylase and Remodeling the Intestinal Microenvironment to Alleviate Depressive-Like Behavior in Mice

Inhibition of JNK ameliorates depressive-like behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation

Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function

Takeda G Protein–Coupled Receptor 5 Modulates Depression-like Behaviors Via Hippocampal CA3 Pyramidal Neurons Afferent to Dorsolateral Septum

Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E

Fr‑HMGB1 and Ds‑hmgb1 Activate the Kynurenine Pathway Via Different Mechanisms in Association with Depressive‑like Behavior

JSH-23 Prevents Depressive-Like Behaviors in Mice Subjected to Chronic Mild Stress: Effects on Inflammation and Antioxidant Defense in the Hippocampus

HIPK2 Mediates M1 Polarization of Microglial Cells Via STAT3: A New Mechanism of Depression-Related Neuroinflammation.

Akt-mediated regulation of antidepressant-sensitive serotonin transporter function, cell-surface expression and phosphorylation

Effects of Serotonin and Serotonergic Agonists and Antagonists on the Production of Interferon-γ and Interleukin-10

Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation